Inventor · disambiguated record
Zachary Gale-Day
Also filed as: GALE-DAY ZACHARY
0 granted patents·6 pending applications·0 citations·filing 2017–2023
Files withVERTEX PHARMA6
Top patents by PatentIndex Score
6 records- 0160US2025136612A14',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0260US2025195483A1Spiro piperidine derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0359US2025171459A12-methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0453US2023159504A17- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0552US2023159521A11h-pyrazolo[4,3-g]isoquinoline and 1h-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0639US2018251431A11,3-substituted pyrazole compounds useful for reduction of very long chain fatty acid levelsVERTEX PHARMA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zachary Gale-Day files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →